Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Colorectal Disease
Published in: International Journal of Colorectal Disease 3/2004

01-05-2004 | Review

Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities

Authors: C. Knorr, B. Reingruber, T. Meyer, W. Hohenberger, C. Stremmel

Published in: International Journal of Colorectal Disease | Issue 3/2004

Login to get access

Abstract

Background and aims

Intraperitoneal carcinomatosis accounts for 25–35% of recurrences of colorectal cancer. Studies demonstrate that peritoneal carcinomatosis is not necessarily a terminal condition with no options for treatment or cure.

Results

The combination of aggressive cytoreductive surgery and intra-abdominal hyperthermia chemotherapy improves long-term overall survival in selected patients but is a time-consuming procedure (approx. 12 h) and entails high mortality (5%) and morbidity (35%)). Most commonly used drugs are mitomycin C and platinum compounds, which have synergistic toxic effects on tumor cells when hyperthermia is applied.

Conclusion

Since combined treatment seems promising only in peritoneal carcinomatosis stages I and II, the precondition for a reasonable combined treatment is careful staging. The mode of chemotherapy, the kind of drugs used for chemoperfusion, the timing of surgery, and the role of additional systemic chemotherapy must be evaluated in randomized studies.
Literature
1.
Becker HD, Hohenberger W, Junginger T, Schlag PM (2002) Chirurgische Onkologie. Thieme, Stuttgart, pp 399–436
2.
Chu DZ, Lang NP, Thompson C, et al (1989) Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 63:364–367PubMed
3.
Brodsky JT, Cohen AM (1991) Peritoneal seeding following potentially curative resection of colonic carcinoma: implications for adjuvant therapy. Dis Colon Rectum 34:723–727PubMed
4.
Sugarbaker PH (1994) Intraperitoneal chemotherapy and cytoreductive surgery for prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Dis Colon Rectum 37:115–122PubMed
5.
Zoetmulder FAN (1996) Cancer cell seeding during abdominal surgery. Experimental studies. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management. Kluwer, Boston, pp 155–161
6.
Shepherd NA, Baxter KJ, Love SB (1997) The prognostic importance of peritoneal involement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102PubMed
7.
Hase K, Ueno H, Kuranga N, et al (1998) Intraperitoneal exfoliated cancer cells in patients with colorectal cancer. Dis Colon Rectum 41:1134–1140PubMed
8.
Solomon MJ, Egan M, Roberts RA, et al (1997) Incidence of free colorectal cancer cells on the peritoneal surface. Dis Colon Rectum 40:1294–1298PubMed
9.
Vogel P, Rüschoff J, Kümmel S, et al (2000) Prognostic value of microscopic peritoneal dissemination. Dis Colon Rectum 1:92–100
10.
Schott A, Vogel I, Krueger U, et al (1998) Isolated tumor cells are frequently detectable in peritoneal cavity of gastric and colorectal cancer patients and serve as new prognostic marker. Ann Surg 227:327–379CrossRef
11.
Minsky BD, Mies C, Rich TA, et al (1988) Potential curative surgery of colon cancer: patterns of failure and survival. J Clin Oncol 6:106–118PubMed
12.
Dawson LE, Russell AH, Tong D, et al (1983) Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 32:95–99
13.
Sadeghi B, Arvieux C, Glehen O, et al (2000) Peritoneal carcinomatosis from non-gynecologic malignancies. Cancer 88:358–363CrossRefPubMed
14.
Ketcham AS, Hoye RC, Pilch YH, Morton DL (1970) Delayed intestinal obstruction following treatment for cancer. Cancer 25:406–410PubMed
15.
McCarthy JD (1986) A strategy for intestinal obstruction of peritoneal carcinomatosis. Arch Surg 21:1081–1082
16.
Weill FS, Costats R, Guetarini S, Maltoni I, Rohmer P (1990) Diagnostic echographiques des metastases peritoneales ches les maladies ascitiques. J Radiol 71:365–368PubMed
17.
Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636PubMed
18.
Gilly FN, Carry PY, Sayag AC (1994) Regional chemotherapy with mitomycin C and intraoperative hyperthermia for digestive cancers with peritoneal carcinomatosis. Hepatogastroenterology 41:124–129PubMed
19.
Pestieau SR, Sugerbaker PH (2000) Treatment of primary colon cancer with peritoneal carcinomatosis. Dis Colon Rectum 43:1341–1348PubMed
20.
Saltz LB, Cox JV, Blanke C, et al (2000) Irinotecan plus fluorouracil for metastatic colorectal cancer. N Engl J Med 343:905–914
21.
Gunderson LL, Sosin H, Levitt S (1985) Extrapelvic colon areas of failure in a reoperation serious: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 11:731–741PubMed
22.
Weisberger AS, Levine B, Storaasli JP (1955) Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. JAMA 159:1704–1707
23.
Elias D, Bonnay M, Puizillou JM, et al (2002) Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmocokinetics and tissue distribution. Ann Oncol 13:267–272CrossRefPubMed
24.
Scheithauer W, Kornek GV, Marczell A, et al (1998) Combined intravenous and intraperitoneal chemotherapy with fluoruracil+leucovorin vs fluoruracil+levamisol for adjuvant therapy of resected colon carcinoma. Br J Cancer 77:1349–1354PubMed
25.
Vaillant JC, Nordlinger B, Deuffic S, et al (2000) Adjuvant intraperitoneal 5-fluorouracil in high-risk colon cancer. Ann Surg 231:449–456CrossRefPubMed
26.
Graf W, Westlin JE, Pahlman L, Glimelius B (1994) Adjuvant intraperitoneal 5-fluoruracil and intravenous leucovorin after colorectal cancer surgery: a randomised phase II placebo-controlled study. Int J Colorectal Dis 9:35–39PubMed
27.
Elias D, Blot F, El Otmany A, et al (2001) Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92:71–76CrossRefPubMed
28.
Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC (1981) Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumors. Cancer Res 41:1096–1099PubMed
29.
Hahn GM, Shiu EC (1983) Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro. Cancer Res 43:5789–5791PubMed
30.
Armour EP, McEachern D, Wang Z, Corry PM, Martinez A (1993) Sensitivity of human cells to mild hyperthermia. Cancer Res 53:2740–2744PubMed
31.
Reed RA Bedford JS (1980) Thermal tolerance. Br J Radiol 53:920–921PubMed
32.
Ozols RF, Locker GY, Doroshov JH (1979) Pharmacokinetics of Adriamycin and tissue penetration in murine ovarian cancer. Cancer Res 39:3209–3214PubMed
33.
Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29–42PubMed
34.
Gilly FN, Carry PY, Sayag AC (1992) Intraperitoneal chemohyperthermia with mitomycin C in dogs: general biological and anastomotic tolerance. Int J Hyperthermia 8:659–666PubMed
35.
Sugarbaker PH, Gianola FJ, Spreyer JL, et al (1985) Prospective randomised trail of intravenous versus intraperitoneal 5-fluoruracil in patients with advanced primary colon or rectal cancer. Surgery 98:414–421PubMed
36.
Beaujard A, Glehen O, et al (2000) Intraperitoneal chemohyperthermia with Mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 88:2513–2519CrossRef
37.
Kzu M, Koksoy C, Kale T, Demirpence E, Renda N (1998) Experimental study of the effect of preoperative 5-fluorouracil on integrity of colon anastomoses. Br J Surg 85:236–239CrossRefPubMed
38.
Shimizu T, Maeta M, Koga S (1991) Influence of local hyperthermia on the healing of small intestinal anastomoses in the rat. Br J Surg 78:57–59PubMed
39.
Sugerbaker PH, Jablonski KA (1995) Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 221:124–132PubMed
40.
Yonemura Y, Ninomya I, Sugiyama K, et al (1995) Prophylaxis with intraoperative chemo-hyperthermia against peritoneal recurrence of serosal invasion-positive cancer. World J Surg 19:450–455PubMed
Metadata
Title
Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities
Authors
C. Knorr
B. Reingruber
T. Meyer
W. Hohenberger
C. Stremmel
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
International Journal of Colorectal Disease / Issue 3/2004
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-003-0524-x

Other articles of this Issue 3/2004

International Journal of Colorectal Disease 3/2004 Go to the issue

Letter to the Editor

Surgery of rectal cancer: still not a science

Erratum

Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy

Case Report

The clear cell adenocarcinoma of the colon: case report and review of the literature

Original Article

Clinical results after restorative proctocolectomy without diverting ileostomy for ulcerative colitis

Letter to the Editor

Sternal metastasis as initial presentation of a unknown rectal cancer

Original Article

Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle to lower rectal cancers